Cody Parsons, APh, PharmD, BCCCP, says protected pharmacist access lets patients with heart failure be seen more often than typical clinic visits allow.
|Videos|October 31, 2013
Repurposing Drugs That Have Been Deemed Failures
Edmund Pezalla, MD, MPH, national medical director, pharmacy policy and strategy at Aetna, explains how drugs that have been deemed "failures" can sometimes become effective treatments for other conditions.
Advertisement
Edmund Pezalla, MD, MPH, national medical director, pharmacy policy and strategy at Aetna, explains how drugs that have been deemed "failures" can sometimes become effective treatments for other conditions.
The video was shot at the 2013 Drug Information Association (DIA) meeting in Boston, Massachusetts. To watch more videos from Specialty Pharmacy Times, visit our
Advertisement
Related to this article
Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
Doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd (Voceryq) targets HPV-6 and HPV-11 to reduce the surgical burden for adults with recurrent respiratory papillomatosis, a rare airway disease.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Understanding Kratom: Pharmacology, Safety, and Regulation
2
GLP-1 Receptor Agonists and Cancer: Considerations for Specialty Pharmacists
3
What Drives First-Line Immunotherapy Selection in NSCLC? Data, Payers, and Habit
4
Frontline Immunotherapy Options in NSCLC: Are Checkpoint Inhibitors Interchangeable?
5